Ocugen Inc (MEX:OCGN) Stock News, Headlines & Updates
Ocugen Inc Stock News from GuruFocus
- 1
Aug 26, 2024
Ocugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Trial for OCU400 -- Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Marketwired • 7:00am
Aug 08, 2024
Ocugen Provides Business Update with Second Quarter 2024 Financial Results
Marketwired • 6:00am
Aug 05, 2024
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa
Marketwired • 6:00am
Aug 02, 2024
Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
Marketwired • 3:00pm
Aug 01, 2024
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
Marketwired • 9:00pm
Jul 31, 2024
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
Marketwired • 4:00pm
Jul 29, 2024
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
Marketwired • 7:00am
Jul 25, 2024
Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410--A Novel Modifier Gene Therapy
Marketwired • 6:00am
Jun 21, 2024
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
Marketwired • 6:00am
Jun 20, 2024
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400--First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication
Marketwired • 6:00am
Jun 10, 2024
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
Business Wire • 10:00am
Jun 08, 2024
OCUGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm
Marketwired • 8:00pm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm
Marketwired • 8:00pm
Jun 07, 2024
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
PRNewswire • 6:00pm
Ocugen, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
Marketwired • 5:00pm
OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Marketwired • 11:00am
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
Business Wire • 10:00am
Jun 06, 2024
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
PRNewswire • 4:00pm
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PRNewswire • 9:00am
Jun 05, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN
Marketwired • 12:00pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
Marketwired • 11:00am
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
Marketwired • 10:00am
Jun 04, 2024
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm
PRNewswire • 11:00am
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
PRNewswire • 11:00am
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
Marketwired • 10:00am
OCGN DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
PRNewswire • 8:00pm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm
Marketwired • 8:00pm
Jun 03, 2024
OCGN DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm -- OCGN
Marketwired • 5:00pm
Holzer & Holzer, LLC Reminds Shareholders of June 10, 2024 Lead Plaintiff Deadline in Ocugen, Inc. (OCGN) Class Action -- Investors With Losses In Excess of $50,000 Encouraged to Contact the Firm
Marketwired • 1:00pm
May 31, 2024
OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Marketwired • 11:00am
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
PRNewswire • 9:00am
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
Marketwired • 8:00am
May 30, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN
PRNewswire • 2:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news